A Study of LY4064912 in Healthy Participants and With Overweight or Obesity (NCT07152002)
A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4064912 in Healthy Participants and Participants With Overweight or Obesity
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate how well LY4064912 is tolerated and what side effects may occur in healthy participants and participants with overweight and obesity - global. The study drug will be administered either subcutaneously (SC) (under the skin) or infusion intravenously (IV) (into a vein in the arm). Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.
Who can join: Review the eligibility criteria below.
Location: Collaborative Neuroscience Network - CNS — Los Alamitos, California
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- Collaborative Neuroscience Network - CNS — Los Alamitos, California
- ICON Early Phase Services — San Antonio, Texas
- Lilly Centre for Clinical Pharmacology — Singapore,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Overweight or Obesity
- Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US — Walnut Creek, California
- PA Moves Trial - Patient Participants — Pittsburgh, Pennsylvania
- Berries, Inflammation, and Gut Microbiome — Chicago, Illinois
- Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women — Birmingham, Alabama
- The Effects of Long-term Consumption of Full-fat Dairy Products on Satiety, Body Weight and Glycemic Control — Halifax, Nova Scotia
Explore by condition: All Overweight or Obesity clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.